Surmodics to Present at Upcoming Investor Conferences
May 22 2017 - 8:00AM
Business Wire
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
information systems and chief financial officer, will be attending
two upcoming investor conferences.
On Wednesday, May 24, 2017, at 12:30 p.m. PT (2:30 p.m.
CT), company management will make a presentation at the B. Riley
2017 Institutional Investors Conference in Santa Monica,
California.
On Tuesday, June 6, 2017, at 1:30 p.m. ET (12:30
p.m. CT), company management will make a presentation at the
Jefferies Healthcare Conference in New York City.
Live audio webcasts of the presentations can be accessed by
going to the investor relations portion of the Company’s website at
www.surmodics.com and clicking on the webcast icon. Webcasts will
be archived on the Company’s website for 90 days.
About Surmodics, Inc.
Surmodics is the global leader in surface modification
technologies for intravascular medical devices and a leading
provider of chemical components for in vitro diagnostic (IVD) tests
and microarrays. Following two recent acquisitions of Creagh
Medical and NorMedix, the Company is executing a key growth
strategy for its medical device business by expanding to offer
total intravascular product solutions to its medical device
customers. The combination of proprietary surface technologies,
along with enhanced device design, development and manufacturing
capabilities, enables Surmodics to significantly increase the value
it offers with highly differentiated intravascular solutions
designed and engineered to meet the most demanding requirements.
With this focus on offering total solutions, Surmodics’ mission
remains to improve the detection and treatment of disease.
Surmodics is headquartered in Eden Prairie, Minnesota. For more
information about the company, visit www.surmodics.com. The content
of Surmodics’ website is not part of this press release or part of
any filings that the company makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170522005275/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Aug 2024 to Sep 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Sep 2023 to Sep 2024